Liver specific-inhibition of LPCAT3 ameliorates metabolic dysfunction-associated steatotic liver disease - Vijay Kondreddy; Ramchandra Reddy Jala; Jhansi Magisetty (Journal of Molecular Medicine, 2026)

LPCAT3—dependent remodeling of the phospholipids and lipid rafts is essential for vascular proinflammatory signaling and the development of atherosclerosis - Vijay Kondreddy; Jhansi Magisetty; Pranshuta Rawat; Muralidharan Kathirvel; Ramchandra Reddy Jala; B. L. A. Prabhavathi Devi; Sunil K. Singh (Inflammation Research, 2025)